Many serious pulmonary diseases, including genetic lung diseases, lack an effective treatment other than the most extreme: lung transplant. A team at Boston Children's Hospital envisions a much better option: cell therapy, ...
Jun 23, 2022
0
122
Antibiotics inappropriately prescribed to nonhospitalized children resulted in at least $74 million in excess health-care costs in the U.S. in 2017, according to a new study from Washington University School of Medicine in ...
May 26, 2022
0
51
The body's innate immune system, active from birth, is the first line of defense against viruses and other pathogens that cause disease. Using vaccination as an example, after receiving a vaccine, pain, redness, or swelling ...
May 25, 2022
0
179
A new study helps explain how the virus that causes herpes might change during transmission between partners and over time during a long-term infection within a human host, which could have implications for future treatment ...
May 25, 2022
0
70
The cornea—the transparent protective outer layer of the eye critical to helping us see—produces a delicate and limited immune response to fight infections without damaging our vision, according to a new study from the ...
May 24, 2022
0
87
McMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.
May 17, 2022
0
76
Viruses in the herpesvirus family are leading causes of birth defects, blindness, and failed organ transplants worldwide. Antiviral drugs can combat these viruses, but patients often develop resistance to the drugs—rendering ...
May 12, 2022
0
47
A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system. The virus, ...
May 11, 2022
0
52
Globally, breakthrough COVID-19 infections among vaccinated people are increasing, raising concerns about the durability of protection against emerging, highly contagious variants of concern. A study publishing May 5th in ...
May 5, 2022
0
152
A team of researchers from the French health care company Sanofi, working with the National Institutes of Health and the National Cancer Institute in the U.S., has developed two new vaccines against Epstein-Barr infections. ...
